Health Encyclopedia

Superficial thrombophlebitis

Definition

Thrombophlebitis involves inflammation of a vein caused by a blood clot inside. With superficial thrombophlebitis, the clot is in a vein just below the surface of the skin.

Causes, incidence, and risk factors

Superficial thrombophlebitis may occur after the recent use of an intravenous (IV) line, after trauma to the vein, or for no apparent reason in persons at risk for thrombophlebitis.

Risks for superficial thrombophlebitis include the following:

Disorders that involve increased blood clotting
Infection
Varicose veins
Chemical irritation of the area
Sitting or being immobilized for a prolonged period

The risk is also increased in women who are or were recently pregnant, and by the use of oral contraceptives.

Superficial thrombophlebitis may be associated with Factor V Leiden, prothrombin gene mutation, and, occasionally, abdominal cancers (such as carcinoma of the pancreas), deep vein thrombosis, and thromboangiitis obliterans.

Symptoms

Skin redness or inflammation along a superficial vein
Warmth of tissue around a superficial vein
Tenderness or pain along a superficial vein (worse when pressure is applied)
Limb pain
Hardening of a superficial vein (induration) -- the vein feels cord-like

Signs and tests

Your health care provider will diagnose superficial thrombophlebitis based primarily on the appearance of the extremity. Frequent checks of the pulse, blood pressure, temperature, skin condition, and circulation may be required.

The diagnosis of superficial thrombophlebitis may be confirmed with the following tests:

Doppler ultrasound
Duplex ultrasound
Venography

If infection is suspected, cultures of the skin or blood cultures may be performed.

Superficial thrombophlebitis may be associated with deficient blood levels of:

Antithrombin III (AT-III)
Protein C (PC)
Protein S (PS)

Treatment

The goals of treatment are reduction of pain and inflammation, and prevention of complications.

If a catheter or IV line produced the thrombophlebitis, it should be removed.

To reduce discomfort and swelling, support stockings and elevation of the affected extremity are recommended.

Medications to treat superficial thrombophlebitis may include the following:

Analgesics for pain
Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation
Intravenous anticoagulants followed by oral anticoagulants to reduce the likelihood of clotting

If deeper clots (deep vein thrombosis) are also present, your provider may prescribe thrombolytic drugs to dissolve an existing clot. Antibiotics are prescribed if infection is present.

Surgical removal (phlebectomy), stripping, or sclerotherapy of the affected vein are occasionally needed to treat large varicose veins or to prevent further episodes of thrombophlebitis in predisposed patients.

Expectations (prognosis)

Superficial thrombophlebitis is usually a benign and short-term condition. Symptoms generally subside in 1 to 2 weeks, but hardness of the vein may remain for much longer.

Complications

Complications of superficial thrombophlebitis are rare. Possible problems may include the following:

Infections (cellulitis)
Gangrene (tissue death)
Septic shock
Deep vein thrombosis
Pulmonary embolism (often without symptoms)

Calling your health care provider

Call for an appointment with your provider if symptoms indicate superficial thrombophlebitis may be present.

Call your provider if you have been diagnosed with superficial thrombophlebitis and your symptoms do not improve with treatment, or if your symptoms worsen. Call the provider if any new symptoms occur, such as entire limb becoming pale, cold, or swollen, or if chills and fever develop.

Prevention

If an intravenous line is in use, the risk of superficial thrombophlebitis may be reduced by routine rotation of the IV site and immediate removal of the IV line if signs of inflammation develop.

Whenever possible, limb immobilization should be avoided.

Review Date:9/11/2006
Reviewed By:Corey Cutler, MD, MPH, FRCP(C), Assistant Professor of Medicine, Harvard Medical School; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.